Capecitabine: all 1,069 studies that test it
Page 11 of 11. Open to participants first (152), then studies with results posted, then the rest; newest registration first within each.
- Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic CancerWithdrawnNCT00118300Phase 1
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal CancerWithdrawnNCT00118105Phase 2
- Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast CancerCompletedNCT00114816Phase 3
- Capecitabine, Bevacizumab, and Radiation Therapy Followed By Gemcitabine and Bevacizumab in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By SurgeryCompletedNCT00114179Phase 2
- Carboplatin, Capecitabine, and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00114153Phase 1
- Trastuzumab and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00107393Phase 2
- AZD2171 + Chemotherapy in Advanced NSCLC, Colorectal Cancer, or Other Cancer Suitable for Treatment With Capecitabine (Non-Small Lung Cancer Patients Closed to Enrollment as 8/9/07)CompletedNCT00107250Phase 1
- Capecitabine and Oxaliplatin in Treating Older Patients With Metastatic Colorectal CancerCompletedNCT00104689Phase 2
- Title XELOX FOR SALIVARY GLAND CANCERSTerminatedNCT00101075Phase 2
- Capecitabine For Nasopharyngeal CancerCompletedNCT00095901Phase 2
- S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWithdrawnNCT00095641Phase 2
- Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast CancerCompletedNCT00088998Phase 2
- A Study of Capecitabine In Combination With Docetaxel vs Capecitabine Followed by Docetaxel As First-Line Treatment For Metastatic Breast CancerTerminatedNCT00087620Phase 4
- Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal CancerTerminatedNCT00087334Phase 1/2
- Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the RectumCompletedNCT00086931Phase 1/2
- Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the GallbladderCompletedNCT00084942Phase 2
- Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid TumorsCompletedNCT00084734Phase 1
- GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsCompletedNCT00084643Phase 1
- Intensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal CancerCompletedNCT00084591Phase 1
- Irinotecan and Capecitabine in Treating Women With Advanced Breast CancerCompletedNCT00083148Phase 1
- Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast CancerCompletedNCT00081796Phase 3
- Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the RectumTerminatedNCT00081224Phase 2
- Capecitabine and Tipifarnib in Treating Women With Taxane-Resistant Metastatic Breast CancerCompletedNCT00077363Phase 2
- DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00077077Phase 1
- Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular CarcinomaCompletedNCT00076609Phase 1/2
- Neoadjuvant Radiation Therapy and Capecitabine in Treating Patients With Stage III or Stage IV Colorectal AdenocarcinomaStatus unknownNCT00075556Phase 2
- Irinotecan, Oxaliplatin, and Capecitabine in Treating Patients With Unresectable Solid TumorsCompletedNCT00074321Phase 1
- Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract CancerCompletedNCT00073905Phase 2
- Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal CancerTerminatedNCT00070265Phase 2
- Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast CancerCompletedNCT00070252Phase 1/2
- Leucovorin and Fluorouracil With or Without Oxaliplatin Compared to Capecitabine With or Without Oxaliplatin in Treating Patients With Metastatic Colorectal CancerCompletedNCT00070213Phase 3
- Combination Chemotherapy With or Without Celecoxib in Treating Patients With Metastatic Colorectal CancerCompletedNCT00064181Phase 3
- Oxaliplatin and Bevacizumab (Avastin™) With Either Fluorouracil and Leucovorin or Capecitabine in Treating Patients With Advanced Colorectal CancerCompletedNCT00062426Phase 3
- Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal CancerStatus unknownNCT00058474Phase 3
- S0312, Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) CancerCompletedNCT00058318Phase 2
- Docetaxel and Capecitabine in Treating Patients With Metastatic Cancer of the Stomach or Gastroesophageal JunctionCompletedNCT00054457Phase 2
- LY317615 Plus Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00052273Phase 1
- Capecitabine Compared With Vinorelbine in Treating Women With Metastatic Breast CancerTerminatedNCT00049660Phase 2/3
- S0030: Capecitabine in Treating Older Patients W/Metastatic or Recurrent Colorectal Cancer That Cannot Be Surgically RemovedCompletedNCT00049335Phase 2
- BMS-247550 Plus Capecitabine in Treating Patients With Metastatic Breast CancerStatus unknownNCT00049244Phase 1
- Study of Combined RHUMAB VEGF and Capecitabine-based Chemoradiation for Patients With Locally Advanced Pancreatic CancerCompletedNCT00047710Phase 1
- Combination Chemotherapy in Treating Patients With Advanced Cancer That is Metastatic or Cannot Be Removed By SurgeryCompletedNCT00043121Phase 1
- Capecitabine and Gemcitabine in Treating Patients With Metastatic Kidney CancerCompletedNCT00042965Phase 2
- Oxaliplatin and Capecitabine in Treating Patients With Advanced Esophageal Cancer or Stomach CancerCompletedNCT00040859Phase 2
- Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00039442Phase 2
- Gefitinib and Capecitabine in Treating Patients With Advanced Solid TumorsCompletedNCT00039390Phase 1
- Safety, Efficacy and Pharmacokinetic Between Capecitabine and Exisulind in Metastatic Breast Cancer PatientsCompletedNCT00037609Phase 1/2
- Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic CancerCompletedNCT00032175Phase 3
- Capecitabine and Paclitaxel in Treating Patients With Metastatic Breast CancerCompletedNCT00031876Phase 1/2
- Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic CancerCompletedNCT00030732Phase 3
- Capecitabine in Treating Women With Advanced or Metastatic Breast CancerStatus unknownNCT00026442Phase 2
- Hepatic Arterial Infusion Plus Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the LiverCompletedNCT00026234Phase 2
- Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid TumorCompletedNCT00021047Phase 1/2
- Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel CancerCompletedNCT00019773Phase 1
- Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00016926Phase 2
- Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsCompletedNCT00010023Phase 1
- Combination Chemotherapy Before Surgery in Treating Women With Breast CancerCompletedNCT00008034Phase 1
- Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity CancerTerminatedNCT00006812Phase 2
- Combination Chemotherapy in Treating Patients With Advanced Solid TumorsCompletedNCT00006465Phase 1
- Capecitabine, Paclitaxel, and Trastuzumab in Treating Patients With Metastatic Breast CancerCompletedNCT00006108Phase 1/2
- Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone TherapyCompletedNCT00006023Phase 2
- Oxaliplatin Plus Capecitabine in Treating Patients With Metastatic or Recurrent Solid TumorCompletedNCT00005839Phase 1
- Paclitaxel and Capecitabine in Treating Women With Metastatic Breast CancerCompletedNCT00005649Phase 2
- Capecitabine and Oxaliplatin in Treating Patients With Advanced or Metastatic Colorectal CancerCompletedNCT00004187Phase 1/2
- Capecitabine in Treating Patients With Malignant MesotheliomaCompletedNCT00004183Phase 2
- Capecitabine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00004012Phase 2
- Capecitabine and Vinorelbine in Treating Older Women Who Have Metastatic Breast Cancer With or Without Bone InvolvementCompletedNCT00003902Phase 1/2
- Irinotecan and Capecitabine in Treating Patients With Solid TumorsCompletedNCT00003867Phase 1
- Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerCompletedNCT00003704Phase 1